| Symbol | IMVT |
|---|---|
| Name | IMMUNOVANT, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 320 WEST 37TH STREET,6TH FLOOR, NEW YORK, New York, 10018, United States |
| Telephone | +1 917 580-3099 |
| Fax | — |
| — | |
| Website | https://www.immunovant.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001764013 |
| Description | Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The companys product includes IMVT-1401 targets the neonatal Fc receptor (FcRn). Additional info from NASDAQ: |
Gloria Melanie 🔴 sold 17.7K shares of Immunovant, Inc. (IMVT) at $38.95 Transaction Date: Jun 26, 2026 | Filing ID: 000075
Read moreStout Jay S 🔴 sold 40.0K shares of Immunovant, Inc. (IMVT) at $38.94 ($1.5M) Transaction Date: Jun 26, 2026 | Filing ID: 000074
Read moreVan Tuyl Christopher 🟡 adjusted position in 17.8K shares (1 derivative) of Immunovant, Inc. (IMVT) at $38.96 ($1.2M) Transaction Date: Jun 26, 2026 | Filing ID: 000073
Read moreGirao Tiago 🟡 adjusted position in 10.0K shares (1 derivative) of Immunovant, Inc. (IMVT) at $38.46 Transaction Date: Jun 26, 2026 | Filing ID: 000072
Read moreDirector Pande Atul 🟡 adjusted position in 1.5K shares (1 derivative) of Immunovant, Inc. (IMVT) at $38.01 Transaction Date: Jun 26, 2026 | Filing ID: 000071
Read moreVan Tuyl Christopher 🔴 sold 2.6K shares of Immunovant, Inc. (IMVT) at $35.39 Transaction Date: Jun 18, 2026 | Filing ID: 000006
Read moreDirector Pande Atul 🟡 adjusted position in 1.5K shares (1 derivative) of Immunovant, Inc. (IMVT) at $34.02 Transaction Date: Jun 15, 2026 | Filing ID: 000069
Read more📋 Atul Pande (Director) plans to sell 6K shares of IMMUNOVANT, INC. (at $33.62 each, total $202K) Filed: Jun 15, 2026 | ID: 006090
Read moreDirector Fromkin Andrew J. 🟡 adjusted position in 222.0K shares (4 derivative) of Immunovant, Inc. (IMVT) at $33.56 ($10.7M) Transaction Date: May 28, 2026 | Filing ID: 000004
Read moreGloria Melanie 🔴 sold 3.1K shares of Immunovant, Inc. (IMVT) at $32.95 Transaction Date: May 20, 2026 | Filing ID: 000067
Read more